Peer review is a positive, formative process and the new, streamlined scheme will be a key driver for service improvements and individual development across the UK over the next few years.
We recommend rheumatology departments should participate in peer review on a 5-yearly basis as a means to facilitate improvement in clinical services and to ensure basic core standards are met.
The benefits of peer review are multi-factorial and can be both at an organisational level (e.g. in line with CQC, supporting specialist commissioning etc) and at an individual level through providing evidence for CPD and revalidation purposes.
In regions where peer review is active the process is seen as mutually beneficial and educational for reviewers and those reviewed. The outcome of visits commonly addresses staffing needs and results in expansion of nursing, medical, secretarial or AHP jobs.